![](https://www.pymnts.com/wp-content/uploads/2023/02/Shutterstock_1156531687.jpg)
European Parliament co-rapporteurs Brando Benifei and Dragoș Tudorache have proposed a number of amendments to the Artificial Intelligence Act in hopes of reaching a workable compromise and closing negotiations in coming days, Euractiv reports.
Issues left to be finalized include a list of high-risk AI uses, prohibited practices and key concept definitions. A category has been added to cover generative AI systems, like ChatGPT, considering AI-generated text that could be mistaken as human-made is high risk.
The AI Act’s Annex III lists critical areas with specific use cases.
In a compromise version of Annex III circulated on Monday (6 February), the co-rapporteurs extended the notion of biometric ID and categorisation to biometric-based systems like Lensa, an app that can generate avatars based on a person’s face for use in digital ID systems.
As the co-rapporteurs want live biometric identification in publicly accessible spaces to be banned altogether, the high-risk use case has been limited to ex-post identification. For privately-accessible spaces, both live and ex-post identification have been added to the list.
Moreover, use cases include remote biometric categorisation in publicly-accessible spaces and emotion recognition systems.
Discussions over the AI act are still expected to cotinue in the coming days as further compromises are reached.
Read On: Regulating Artificial Intelligence Requires Balancing Rights, Innovation
Featured News
Microsoft President Grilled on Security and China Ties in Congressional Hearing
Jun 16, 2024 by
CPI
EU Set to Approve Lufthansa’s 41% Stake Acquisition in ITA Airways
Jun 16, 2024 by
CPI
Apple and Meta Face Imminent Charges Under EU Digital Markets Act
Jun 16, 2024 by
CPI
Discover Financial Services’ Pulse Network Settles Antitrust Lawsuit Against Visa
Jun 16, 2024 by
CPI
US Soccer Antitrust Battle Heads to Jury Trial
Jun 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 31, 2024 by
CPI
AI and Antitrust Considerations in U.S. Health Care
May 31, 2024 by
CPI
Uncertainty in the Bottom Line: New Antitrust Scrutiny and Enforcement in Private Equity Transactions
May 31, 2024 by
CPI
Effecting M&A Diligence When Competitors Are Involved
May 31, 2024 by
CPI
AI, Pharmaceutical Sector, and EU Competition Law and Policy: What Does the Future Look Like?
May 31, 2024 by
CPI